Abstract:OBJECTIVE To evaluate the effect of intravenous immunoglobulin (IVIG) and vitamin C on the progression of experimental autoimmune myocarditis(EAM). METHODS Fifty-two Balb/c mice were randomized into six groups: The blank group received no treatment, the remaining 5 groups were immunized with 100mug emulsified porcine myosin at d 1 and d 7. Different agents were injected from d 1, SVitC group:150 mg/kg*d(-1)vitamin C; LVitC group: 300 mg/kg*d(-1)vitamin C; IVIG group: 1 g/kg*d(-1)IVIG; IVIG+VitC group: 1 g/kg*d(-1)IVIG and 150 mg/kg*d(-1)vitamin C; The control group same volume of normal saline. All mice were sacrificed at d 21, and serum TNF-alpha levels were detected with enzyme linked immunosorbent assay (ELISA). The ratio of heart to body weight(C/W), spleen to body weight(S/W) and kidney to body weigh(R/W) were calculated. The spleens and heart were examined pathologically and/or immunohistochemically. RESULT Compared with those of control group, inflammatory cells infiltration in the myocardium and calcification in the pericardiume in SVitC and LVitC groups were extenuated. There were inflammatory cells infiltrating in the myocardium sparely and no calcification in the pericardium in IVIG and IVIG+VitC groups. The size of spleens enlarged especially in IVIG and IVIG+VitC groups. White and red pulps of spleens were hyperplastic microscopically. The C/W of treatment groups decreased significantly compared with that of control group. The S/W of therapy groups and control group was significantly higher than that of blank group; and the S/W of IVIG and IVIG + VitC groups was significantly higher than that of SVitC and LVitC groups. The R/W in each groups had no significant difference. The TNF-alpha level in SVitC and LVitC groups was a little lower than that in control group; TNF-alpha level in IVIG and IVIG+VitC groups was significantly lower than that of control group. Wide fluorescence stripe was found along extracellular matrix surrounding the damaged cardiomyocytes of control group. Both density and intensity of fluorescence in SVitC and LVitC groups were lower than those of control group. There were much wider fluorescence stripe and strengthened intensity in IVIG and IVIG + VitC groups. The myofilaments were in wild disorder and sarcomere had severe breakage in control group. Moreover, chondriosome hypertrophy and vacuolar degeneration were found. The damage lessened in SVitC and LVitC groups. Both myofilaments and sarcomeres in IVIG and IVIG + VitC groups were almost normal, and the chondriosome was normal. CONCLUSION IVIG and vitamin C have some protective and therapeutic effect on the progression of EAM by decreasing pathological damage of myocardium and depressing TNF-alpha production, and IVIG combined with vitamin C is more effective.

Amelioration of Myocarditis by HVEM-overexpressing Dendritic Cells Through Induction of IL-10-producing Cells

Amelioration of experimental autoimmune myocarditis by HVEM-overexpressing dendritic cells through induction of IL-10-producing cells

[Effect of Intravenous Immunoglobulin and Vitamin C on Progression of Experimental Autoimmune Myocarditis in Mice].

Development of an improved animal model of experimental autoimmune myositis.

Alteration of IL-17 Related Protein Expressions in Experimental Autoimmune Myocarditis and Inhibition of IL-17 by IL-10-Ig Fusion Gene Transfer.

Hmgb1 Blockade Attenuates Experimental Autoimmune Myocarditis and Suppresses Th17-Cell Expansion

Expression and Significance of TNFSF14 and HVEM in the Experimental Autoimmune Myocarditis

Single-Cell RNA Sequencing to Dissect the Immunological Network of Autoimmune Myocarditis

The Role of Herpesvirus Entry Mediator As a Negative Regulator of T Cell–mediated Responses

Treatment and Prevention of Experimental Autoimmune Myocarditis with CD28 Superagonists.

Prevention of Experimental Autoimmune Myocarditis by Hydrodynamics-Based Naked Plasmid DNA Encoding CTLA4-Ig Gene Delivery

In vivo delivery of adenoviral vector containing interleukin-17 receptor a reduces cardiac remodeling and improves myocardial function in viral myocarditis leading to dilated cardiomyopathy.

Molecular mechanisms promoting progression of autoimmune myocarditis to dilated cardiomyopathy.

Hydrodynamics-Based Delivery Of An Interleukin-1 Receptor Ii Fusion Gene Ameliorates Rat Autoimmune Myocarditis By Inhibiting Il-1 And Th17 Cell Polarization

Inhibition of Microrna-155 Ameliorates Experimental Autoimmune Myocarditis by Modulating Th17/Treg Immune Response

Successful Treatment of Experimental Autoimmune Myocarditis by Adenovirus-Mediated Gene Transfer of Antisense CIITA.

Human Umbilical Cord Mesenchymal Stem Cells Alleviate Acute Myocarditis by Modulating Endoplasmic Reticulum Stress and Extracellular Signal Regulated 1/2-Mediated Apoptosis

Effects of 1, 25-Dihydroxyvitamin D3 on Experimental Autoimmune Myocarditis in Mice

Adenovirus-mediated ICOSIg gene transfer alleviates cardiac remodeling in experimental autoimmune myocarditis.

Direct Gene Transfer with IP-10 Mutant Ameliorates Mouse CVB3-induced Myocarditis by Blunting Th1 Immune Responses.

PGE2 Ameliorated Viral Myocarditis Development and Promoted IL-10-producing Regulatory B Cell Expansion Via MAPKs/AKT-AP1 Axis or AhR Signaling.